GMP Cytokine Market Set to Grow at 8.4% CAGR to 2031, Led by Bio-Techne, PeproTech, CellGenix Amidst Rising Demand for Immunotherapies and Personalized Medicine.

Friday, Dec 12, 2025 3:27 pm ET1min read
TECH--

The global GMP cytokine market is expected to grow at an 8.4% CAGR from 2025 to 2031, driven by increasing demand for immunotherapies, adoption of personalized medicine, and focus on cancer research. Key players include Bio-Techne, PeproTech, and CellGenix. Emerging trends include a shift towards personalized medicine, bioprocess optimization, and adoption of advanced analytics and AI. Strategic growth opportunities lie in cell and gene therapy, cancer immunotherapy, and vaccine development.

GMP Cytokine Market Set to Grow at 8.4% CAGR to 2031, Led by Bio-Techne, PeproTech, CellGenix Amidst Rising Demand for Immunotherapies and Personalized Medicine.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet